BBVA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BBVA is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown solid financial growth in the latest quarter and analysts generally maintain positive ratings, the recent price trend is negative, and there are no strong trading signals or catalysts to suggest an immediate entry point. The options data indicates bearish sentiment, and technical indicators do not provide clear support for a buy decision. Holding off for a better opportunity may be more prudent.
The MACD is positive but contracting, RSI is neutral at 42.461, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 21.01, with support at 20.414 and resistance at 21.606. Overall, the technical indicators suggest indecision in the market.
The company's financials for Q4 2025 showed strong YoY growth in revenue (+11.72%), net income (+14.02%), and EPS (+16.28%). Analysts like JPMorgan and Citi maintain overweight and buy ratings, citing strong shareholder returns and exposure to high-growth markets like Mexico and South America.
The stock has declined by 2.65% in the regular market and 1.49% in pre-market trading. Analysts like RBC Capital have downgraded the stock, citing full valuation. Options data reflects bearish sentiment, and technical indicators do not suggest a strong upward trend. Additionally, there is no recent news or significant trading activity by insiders or hedge funds to act as a catalyst.
In Q4 2025, BBVA reported revenue of €12.1 billion, up 11.72% YoY. Net income increased to €2.83 billion, up 14.02% YoY, and EPS rose by 16.28%. These figures indicate strong financial performance and growth trends.
Analysts have mixed views. JPMorgan and Citi maintain buy/overweight ratings with price targets around €23.30-€23.50, citing strong growth potential and shareholder returns. However, RBC Capital downgraded the stock to sector perform, citing full valuation. The average price target remains slightly above the current price, but recent downgrades suggest caution.
